ITGAX and melanoma: In order to investigate cancer–immune cell interactions after plasma treatment, monocyte‐derived CD11c+ dendritic cells were challenged with cell trace violet (CTV)‐labeled plasma‐oxidized melanoma cells (oxmel; Figure 3i).